| Literature DB >> 34205910 |
Yoshiyuki Adachi1, Hidetaka Nakata2, Tetsuya Tanabe2, Daisuke Yamanaka1, Takashi Kanno1, Ken-Ichi Ishibashi3, Naohito Ohno1.
Abstract
To overcome the limitations of the Limulus amebocyte lysate (LAL) assay method for the diagnosis of invasive fungal infection, we applied a reaction system combining recombinant β-glucan binding proteins and a scanning single-molecule counting (SSMC) method. A novel (1→3)-β-D-glucan recognition protein (S-BGRP) and a (1→6)-β-glucanase mutant protein were prepared and tested for the binding of (1→6)-branched (1→3)-β-D-glucan from fungi. S-BGRP and (1→6)-β-glucanase mutant proteins reacted with β-glucan from Candida and Aspergillus spp. Although LAL cross-reacted with plant-derived β-glucans, the new detection system using the SSMC method showed low sensitivity to plant (1→3)-β-D-glucan, which significantly improved the appearance of false positives, a recognized problem with the LAL method. Measurement of β-glucan levels by the SSMC method using recombinant β-glucan-binding proteins may be useful for the diagnosis of fungal infections. This study shows that this detection system could be a new alternative diagnostic method to the LAL method.Entities:
Keywords: (1→6)-β-glucanase; Limulus amebocyte lysate assay; beta-glucan recognition protein; invasive fungal infection; scanning single-molecule counting method
Mesh:
Substances:
Year: 2021 PMID: 34205910 PMCID: PMC8198189 DOI: 10.3390/ijms22115977
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Schematic diagrams of molecular counting interacted with β-D-glucans. AF647-labeled molecules bound to BG complex were eluted (a), the elution sample was scanned, and a molecule in the confocal site was counted (b).
BG content of CSBG, ASBG, Pollen BG, and laminarin in the LAL test.
| BGs (10 ng/mL) | LAL (pg/mL) (Pachyman Equivalents) |
|---|---|
| CSBG | 490 ± 48 |
| ASBG | 819 ± 17 |
| Pollen BG | 51.6 ± 0.9 |
| Laminarin | 338 ± 2 |
BG content in the various BG preparations was determined by factor G-based LAL assay as a Pachyman equivalent in the clinical laboratory of SRL, Inc. Each value represents a mean ± standard deviation (SD) of three measurements.
Figure 2Detection of various BGs using S-BGRP and 16BGM. CSBG (a), ASBG (b), Pollen BG (c), and laminarin (d) are detected using 0.5 μg/mL AF647-labeled S-BGRP and 0.1 μg/mL biotin-labeled 16BGM. Each value represents a mean ± standard deviation (SD). n = 6 for 0 g/mL; n = 3 for all other concentrations.
Figure 3Comparison of LAL test and SSMC. 0–1000 pg/mL CSBG (two-fold serial dilution) are detected using LAL test and SSMC. A total of 0.5 μg/mL AF647-labeled S-BGRP and 0.1 μg/mL biotin-labeled 16BGM were used in SSMC.
Figure 4Spiking of CSBG into human sera and recovery test. A total of 50 pg/mL CSBG spiked into human sera were detected using 0.5 μg/mL AF647-labeled S-BGRP and 0.1 μg/mL biotin-labeled 16BGM. An error bar of average represents SD.
Comparison of LAL and SSMC methods for determination of BG content in intravenous immunoglobulin.
| Intravenous Immunoglobulin (IVIG) | LAL (pg/mL) | SSMC (pg/mL) |
|---|---|---|
| Venilon-I | <5.0 | <32.4 |
| Venoglobulin IH 5% | 48.4 | <32.4 |
| Gammagard | 36.8 | <32.4 |
| Glovenin-I | 73.9 | <32.4 |
| Polyglobin-N | 60.6 | 41.1 |
| Sanglopor | 1570 | <32.4 |
BG content in the various immunoglobulin medicine products was determined by factor G-based LAL assay as a Pachyman equivalent in the clinical laboratory of SRL, Inc., and by SSMC as a CSBG equivalent, as described in Materials and Methods.